Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Carla (DeMuro) Romano"'
Autor:
Allison Martin Nguyen, Carmen La Rosa, Alexandra G. Cornell, Mandel R. Sher, Jonathan A. Bernstein, Surinder S. Birring, Carla (DeMuro) Romano, Margaret Mayorga, Mirline Milien, Claire Ervin
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: Chronic cough, a cough lasting >8 weeks, includes refractory chronic cough (RCC) and unexplained chronic cough (UCC). Patient-reported outcome (PRO) measures are needed to better understand chronic cough impacts that matter most to patien
Externí odkaz:
https://doaj.org/article/d4b71c179cce4e80b1b366443357246d
Autor:
Vishal Bali, Jonathan Schelfhout, Mandel R. Sher, Anju Tripathi Peters, Gayatri B. Patel, Margaret Mayorga, Diana Goss, Carla (DeMuro) Romano
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: Chronic cough, defined as a cough lasting 8 or more weeks, affects up to 10% of adults. Refractory chronic cough (RCC) is a cough that is uncontrolled despite comprehensive investigation and treatment of comorbid conditions while unexplai
Externí odkaz:
https://doaj.org/article/56000a32c65346eda33d1d3cb4594dfb
Autor:
Carla (DeMuro) Romano, Lyn Finelli, Sandy Lewis, Valerie Williams, Emily Martin, Matthew Phillips, Todd L. Saretsky, Josephine Norquist
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Respiratory syncytial virus (RSV) causes significant morbidity and mortality in older adults. Despite a number of RSV vaccine candidates in clinical trials, there are no existing disease-specific, self-reported measures that asses
Externí odkaz:
https://doaj.org/article/afe382a223984a7f92f004327720f42c
Autor:
Eldrin F. Lewis, Theresa M. Coles, Sandy Lewis, Lauren M. Nelson, Amy Barrett, Carla DeMuro Romano, Donald E. Stull, Stuart J. Turner, Chunlan G. Chang
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-15 (2019)
Abstract Background This study aimed to develop and provide a psychometric and feasibility pilot evaluation of the Heart Failure (HF) Symptom Tracker (HFaST), a new patient-reported tool designed to facilitate communication between patients and healt
Externí odkaz:
https://doaj.org/article/75dab0f4d76144de960e3c9c61570d68
Autor:
Shanshan Qin, Kristian Vinter Juul, Sandy Lewis, Fredrik L. Andersson, Nicole Williams, Carla DeMuro Romano, Valerie Williams, Stuart Yarr
Publikováno v:
J Clin Sleep Med
STUDY OBJECTIVES: The Nocturia Sleep Quality Scale (NSQS), a novel patient-reported outcomes measure, was developed to assess the impact of sleep disturbance from nocturia. The objective of this study was to assess the psychometric properties of the
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 25(4)
A review of new drug approvals (NDAs) by the US Food and Drug Administration (FDA) for 2006 to 2015 showed that approximately 20% of new drugs had labeling based on patient-reported outcomes (PROs). The purpose of this study was to review labeling te
Autor:
Jaskaran Singh, James W. Murrough, Richard C. Shelton, Carla DeMuro Romano, Geert De Bruecker, Sandy Lewis, Carol Jamieson
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 12:527-537
Clinical outcome assessments may not fully capture patients’ perspectives of treatment benefit or tolerability. Incorporating individual exit interviews might enhance the description of the patient experience of drug effects. The objective of this
Autor:
Fredrik L. Andersson, Sandy Lewis, Amy Barrett, Carla DeMuro Romano, Sonia Ancoli-Israel, Thomas Roth, Valerie Williams
Publikováno v:
Sleep Medicine. 59:101-106
Background/objective Nocturia's impact on sleep causes significant burden for patients. This study aimed to develop a novel patient-reported outcome (PRO) measure, the Nocturia Sleep Quality Scale (NSQS), for the assessment of the impact of nocturia
Publikováno v:
Value in Health. 22:203-209
Objectives To compare US Food and Drug Administration (FDA) and European Medicines Agency (EMA) labeling for evidence based on patient-reported outcomes (PROs) of new oncology treatments approved by both agencies. Methods Oncology drugs and indicatio
Autor:
Sandy Lewis, Patricia A. Russo, Lauren Bartolome, Sibyl Wray, Wendy Su, Emily Evans, R. G. Shah, Carla DeMuro Romano
Publikováno v:
Neurology and Therapy
Introduction Critical gaps exist in the understanding of the continuum of multiple sclerosis (MS) progression, particularly with regard to the patient experience prior to and during the transition from relapsing–remitting MS (RRMS) to secondary-pro